| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |